文献速递外周动脉疾病

腘动脉闭塞累及三分叉时旁路与腔内治疗比较

Comparison of Bypass and Endovascular Intervention for Popliteal Occlusion with the Involvement of Trifurcation for Critical Limb Ischemia.
PubMed 文献 · Ann Vasc Surg · 2019-09-16

该回顾性研究纳入108例腘动脉闭塞累及三分叉的严重肢体缺血患者,65例腔内组、43例开放组。3年免于MALE无差异,腔内组大再干预更多,两组总体生存和无截肢生存无差异。

要点

  • 腔内组3年免于MALE与开放组相似(68.5%对77.2%,P=0.413)。
  • 腔内组大再干预显著多于开放组(P=0.0459)。
  • 两组3年无截肢生存和总体生存无显著差异。

核心结论

  • 随访3年时,腔内治疗组免于MALE与开放旁路组相似。
  • 两组总体生存和无截肢生存无差异,但腔内组大再干预更多。

研究设计与样本

  • 回顾性纳入108例连续手术,腔内组65例,开放组43例。
  • 纳入标准为Rutherford 4和5级、腘动脉闭塞累及三分叉且至少1条膝下动脉流出道通畅。

主要发现

  • 技术成功率开放组100%,腔内组96.9%。
  • 免于MALE 1年和3年:腔内组73.5%和68.5%,开放组84.3%和77.2%(P=0.413)。
  • 3年内大再干预次数腔内组显著多于开放组(P=0.0459)。
  • 无截肢生存30天、1年、3年:腔内组93.7%、79.3%、66.0%,开放组88.4%、77.4%、64.3%(P=0.726)。
  • 早期死亡率开放组9.3%,腔内组1.5%(P=0.060);3年总体生存开放组75.1%,腔内组84.3%。

关键数值与推荐

  • 主要结局为MALE、无截肢生存和早期死亡(至30天)。
  • 次要结局为3年总体生存。

临床怎么用

  • 对于腘动脉闭塞累及三分叉的严重肢体缺血患者,腔内治疗可作为开放旁路的替代选择。
  • 选择腔内治疗时需考虑其大再干预风险较高。

局限性

  • 回顾性研究设计。
  • 样本量有限(共108例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of this study is to analyze the technical aspects and outcomes of the treatment of occlusion of the popliteal artery with the involvement of the trifurcation treated with a bypass (open) and endovascular (endo) approach. METHODS: Overall, 108 consecutive procedures were enrolled retrospectively. Patients were evaluated in 2 groups: the endo group (65 patients) and the open group (43 patients). Primary outcome were MALE (major adverse limb events), amputation-free survival, and early mortality (until 30 days). Secondary outcome was overall survival in 3 years. Inclusion criteria were Rutherford 4 and 5 and occlusion of the popliteal artery with the involvement of trifurcation and, at least, 1 infrapopliteal artery of runoff. RESULTS: Technical success was achieved in 100% of patients in the open and 96.9% of patients in the endo group. Freedom from MALE was 73.5% and 68.5% for 1 and 3 years respectively for the endo group, and 84.3% and 77.2% respectively for the open group (P = 0.413). Considering the total number of major reinterventions executed until 3 years, the reinterventions was statistically more performed in the endo compared to the open group (P = 0.0459). Amputation-free survival for the endo group in 30 days, 1 year, and 3 years was 93.7%, 79.3%, and 66.0%, respectively, and the amputation-free survival for the open group was 88.4%, 77.4%, and 64.3% (P = 0.726). Early mortality was 9.3% for the open group and 1.5% for the endo group (P = 0.060). In 3 years, the overall survival was 75.1% in the open group and 84.3% in the endo group. CONCLUSIONS: In 3 years, follow-up endovascular treatment of occlusion of the popliteal artery with the involvement of the trifurcation has similar time freedom from MALE compared to open approach. Overall and amputation-free survival was not different between the groups besides more reinterventions in patients who underwent endovascular approach.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Biagioni RB, Nasser F, Matielo MF, et al. Comparison of Bypass and Endovascular Intervention for Popliteal Occlusion with the Involvement of Trifurcation for Critical Limb Ischemia. Ann Vasc Surg. 2019. PMID: 31536796. doi:10.1016/j.avsg.2019.07.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。